Correlation Between Microsoft and Coeptis Therapeutics
Can any of the company-specific risk be diversified away by investing in both Microsoft and Coeptis Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Coeptis Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Coeptis Therapeutics, you can compare the effects of market volatilities on Microsoft and Coeptis Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Coeptis Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Coeptis Therapeutics.
Diversification Opportunities for Microsoft and Coeptis Therapeutics
-0.13 | Correlation Coefficient |
Good diversification
The 3 months correlation between Microsoft and Coeptis is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Coeptis Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coeptis Therapeutics and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Coeptis Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coeptis Therapeutics has no effect on the direction of Microsoft i.e., Microsoft and Coeptis Therapeutics go up and down completely randomly.
Pair Corralation between Microsoft and Coeptis Therapeutics
Given the investment horizon of 90 days Microsoft is expected to under-perform the Coeptis Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Microsoft is 4.05 times less risky than Coeptis Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Coeptis Therapeutics is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 1,295 in Coeptis Therapeutics on September 8, 2025 and sell it today you would earn a total of 275.00 from holding Coeptis Therapeutics or generate 21.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Microsoft vs. Coeptis Therapeutics
Performance |
| Timeline |
| Microsoft |
| Coeptis Therapeutics |
Microsoft and Coeptis Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Microsoft and Coeptis Therapeutics
The main advantage of trading using opposite Microsoft and Coeptis Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Coeptis Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coeptis Therapeutics will offset losses from the drop in Coeptis Therapeutics' long position.| Microsoft vs. Eagle Materials | Microsoft vs. Morgan Advanced Materials | Microsoft vs. Materialise NV | Microsoft vs. ARIA Wireless Systems |
| Coeptis Therapeutics vs. Kid Castle Educational | Coeptis Therapeutics vs. Education Management Corp | Coeptis Therapeutics vs. Zane Interactive Publishing | Coeptis Therapeutics vs. Innodata |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |